Clinical Trial Update: Effect of a Specific Phenolic Compound on Blood Pressure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is evaluating the effect of an unspecified phenolic compound on blood pressure. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• unspecified phenolic compound

Snippet

Sponsor: Technological Centre of Nutrition and Health, Spain | Conditions: Cardiovascular Risk Factors, Blood Pressure | Phase 3 | Status: UNKNOWN